Stocksigma LogoStocksigma Logo

Bio Medica Laboratories Reports H1 FY27 Financial Results

Bio Medica Laboratories reported standalone revenue from operations of ₹1,668.64 lakhs for the half-year ended 30th Sep'26, down 9.31% YoY from ₹1,839.90

Bio Medica Laboratories Reports H1 FY27 Financial Results

Bio Medica Laboratories Ltd · Financial Result · 13 Nov 2026, 11:01 pm

Bio Medica Laboratories Reports H1 FY27 Financial Results Bio Medica Laboratories reported standalone revenue from operations of ₹1,668.64 lakhs for the half-year ended 30th Sep'26, down 9.31% YoY from ₹1,839.90 lakhs in H1 FY26. Standalone net profit declined 45.53% YoY to ₹283.81 lakhs compared to ₹521.01 lakhs in the prior-year period. On a consolidated basis, revenue from operations reached ₹2,160.78 lakhs with a net profit of ₹312.54 lakhs. The company raised ₹4,241.25 lakhs via share capital and securities premium, lifting consolidated cash and cash equivalents to ₹2,510.34 lakhs.

Original exchange filing (PDF)

More announcements from Bio Medica Laboratories Ltd

All Bio Medica Laboratories Ltd announcements